Compass Therapeutics, Inc. - COMMON STOCK (CMPX)

Historical Holders from Q4 2021 to Q1 2025

Symbol
CMPX on Nasdaq
CUSIP
20454B104
Type / Class
Equity / COMMON STOCK
Shares outstanding
138M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
101M
Holdings value
$147M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
91
Number of buys
51
Number of sells
-23
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Compass Therapeutics, Inc. - COMMON STOCK (CMPX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ORBIMED ADVISORS LLC 11% $28.9M 15.2M ORBIMED ADVISORS LLC Apr 9, 2024
MPM BioImpact LLC 6.2% $16.3M 8.57M MPM BioImpact LLC Dec 31, 2024
TANG CAPITAL MANAGEMENT LLC 5.4% $14.1M 7.4M TANG CAPITAL MANAGEMENT, LLC Jan 8, 2025
BlackRock, Inc. 5% $13.1M 6.89M BlackRock, Inc. Dec 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C. 4.36% $11.4M 5.99M Adage Capital Management, L.P. Dec 31, 2024

Institutional Holders of Compass Therapeutics, Inc. - COMMON STOCK (CMPX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 1.21M $2.29M +$964K $1.90 8
2024 Q4 101M $147M +$1.18M $1.45 91
2024 Q3 92.2M $170M +$881K $1.84 79
2024 Q2 92.9M $93.4M -$5.27M $1.00 81
2024 Q1 94.6M $187M +$18.2M $1.98 77
2023 Q4 85.9M $134M -$2.57M $1.56 75
2023 Q3 89.7M $177M -$1.7M $1.97 76
2023 Q2 90.5M $288M +$28.7M $3.18 72
2023 Q1 81.5M $267M +$1.8M $3.27 72
2022 Q4 79.8M $401M +$78.8M $5.03 54
2022 Q3 63.9M $146M +$8.15M $2.28 36
2022 Q2 61.9M $164M +$666K $2.65 31
2022 Q1 62.4M $85.4M -$4.07M $1.37 33
2021 Q4 63.6M $202M +$198M $3.17 37